Efficacy and Safety of Fremanezumab in Patients With Episodic and Chronic Migraine and Documented Inadequate Response to 2–4 Classes of Migraine Preventive Medications During the Open-label Period of the Phase 3b FOCUS Study (4379)

Abstract only

Saved in:

Bibliographic Details
Published in:	Neurology Vol. 94; no. 15_supplement
Main Authors:	Ashina, Messoud, Cohen, Joshua, Galic, Maja, Campos, Verena Ramirez, Yang, Ronghua, Ning, Xiaoping, Diener, Hans-Christoph
Format:	Journal Article
Language:	English
Published:	14-04-2020
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!